Market Report Source

Overview

Datamonitor’s Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

• Contains an executive summary and data on value, volume and segmentation

• Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies

• Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

• Includes a five-year forecast of the industry

Highlights

The global biotechnology market grew by 12.6% in 2006 to reach a value of $153.7 billion.

In 2011, the market is forecast to have a value of $271.4 billion, an increase of 76.5% since 2006.

Medical products account for 62.5% of the global market’s biotechnology revenues.

The Americas is the largest region, accounting for 58.3% of the global biotechnology market’s revenues.

Why you should buy this report

• Spot future trends and developments

• Inform your business decisions

• Add weight to presentations and marketing materials

• Save time carrying out entry-level research

Market Definition
The Biotechnology market consists of the non-life Biotechnology sector and the life Biotechnology sector. The value of the market is shown in terms of gross premium incomes. The life Biotechnology sector covers all life Biotechnology products including annuities, which can be linked to retirement savings plans. The non-life Biotechnology sector consists of the accident and health and the property and casualty Biotechnology segments.

The Biotechnology market depends on a variety of economic and non-economic factors and future performance is difficult to predict. The forecast given in this report is not based on a complex economic model, but is intended as a rough guide to the direction in which the market is likely to move. This forecast is based on a correlation between past market growth and growth of base drivers, such as house price growth, GDP growth and long-term interest rates.

Any currency conversions used in the report have been calculated using constant 2005 annual average exchange rates.

For the purpose of this report, Europe comprises Belgium, Asia-Pacific comprises of Australia, China, India, Japan, South Korea, Singapore, and Taiwan.

The Americas comprises the US, Canada, Brazil, and Mexico.

Asia-Pacific comprises Australia, China, India, Japan, South Korea, Singapore, and Taiwan.

The global market comprises Asia-Pacific, Europe, and the Americas.

Table of Contents

CHAPTER 1 Introduction

1.1 What is this report about?

1.2 Who is the target reader?

1.3 How to use this report

1.4 Definitions

CHAPTER 2 Global Biotechnology

2.1 Market Overview

2.2 Market Value

2.3 Market Segmentation I

2.4 Market Segmentation II

2.5 Five Forces Analysis

2.6 Market Forecasts

CHAPTER 3 Biotechnology in Asia Pacific

3.1 Market Overview

3.2 Market Value

3.3 Market Segmentation I

3.4 Market Segmentation II

3.5 Five Forces Analysis

3.6 Market Forecasts

CHAPTER 4 Biotechnology in Europe

4.1 Market Overview

4.2 Market Value

4.3 Market Segmentation I

4.4 Market Segmentation II

4.5 Five Forces Analysis

4.6 Market Forecasts

4.7 Macroeconomic Indicators

CHAPTER 5 Biotechnology in Belgium

5.1 Market Overview

5.2 Market Value

5.3 Market Segmentation I

5.4 Market Segmentation II

5.5 Five Forces Analysis

5.6 Market Forecasts

5.7 Macroeconomic Indicators

CHAPTER 6 Biotechnology in Canada

6.1 Market Overview

6.2 Market Value

6.3 Market Segmentation I

6.4 Market Segmentation II

6.5 Five Forces Analysis

6.6 Market Forecasts

6.7 Macroeconomic Indicators

CHAPTER 7 Biotechnology in China

7.1 Market Overview

7.2 Market Value

7.3 Market Segmentation I

7.4 Market Segmentation II

7.5 Five Forces Analysis

7.6 Market Forecasts

7.7 Macroeconomic Indicators

CHAPTER 8 Biotechnology in France

8.1 Market Overview

8.2 Market Value

8.3 Market Segmentation I

8.4 Market Segmentation II

8.5 Five Forces Analysis

8.6 Market Forecasts

8.7 Macroeconomic Indicators

CHAPTER 9 Biotechnology in Germany

9.1 Market Overview

9.2 Market Value

9.3 Market Segmentation I

9.4 Market Segmentation II

9.5 Five Forces Analysis

9.6 Market Forecasts

9.7 Macroeconomic Indicators

CHAPTER 10 Biotechnology in Italy

10.1 Market Overview

10.2 Market Value

10.3 Market Segmentation I

10.4 Market Segmentation II

10.5 Five forces Analysis

10.6 Market Forecasts

10.7 Macroeconomic Indicators

CHAPTER 11 Biotechnology in Japan

11.1 Market Overview

11.2 Market Value

11.3 Market Segmentation I

11.4 Market Segmentation II

11.5 Five Forces Analysis

11.6 Market Forecasts

11.7 Macroeconomic Indicators

CHAPTER 12 Biotechnology in the Netherlands

12.1 Market Overview

12.2 Market Segmentation I

12.3 Market Segmentation II

12.4 Five Forces Analysis

12.5 Market Forecasts

12.6 Macroeconomic Indicators

CHAPTER 13 Biotechnology in Spain

13.1 Market Overview

13.2 Market Value

13.3 Market Segmentation I

13.4 Market Segmentation II

13.5 Five Forces Analysis

13.6 Market Forecasts

13.7 Macroeconomic Indicators

CHAPTER 14 Biotechnology in the United Kingdom

14.1 Market Overview

14.2 Market Value

14.3 Market Segmentation I

14.4 Market Segmentation II

14.5 Five Forces Analysis

14.6 Market Forecasts

14.7 Macroeconomic Indicators

CHAPTER 15 Biotechnology in the United States

15.1 Market Overview

15.2 Market Value

15.3 Market Segmentation I

15.4 Market Segmentation II

15.5 Five Forces Analysis

15.6 Market Forecasts

15.7 Macroeconomic Indicators

CHAPTER 16 Company Profiles

16.1 Leading Companies

CHAPTER 17 Appendix

17.1 Data Research Methodology

17.2 Report writing team

List of Tables
Table 1: Global Biotechnology Market Value: $ billion, 2002-2006

Table 2: Global Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 3: Global Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 4: Global Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 5: Asia-Pacific Biotechnology Market Value: $ billion, 2002-2006

Table 6: Asia-Pacific Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 7: Asia-Pacific Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 8: Asia-Pacific Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 9: Europe Biotechnology Market Value: $ billion, 2002-2006

Table 10: Europe Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 11: Europe Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 12: Europe Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 13: Europe Exchange Rate, 2002

Table 14: Belgium Biotechnology Market Value: $ billion, 2002-2006

Table 15: Belgium Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 16: Belgium Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 17: Belgium Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 18: Belgium Size of Population (million) , 2002-2006

Table 19: Belgium GDP (1995=100), 2002-2006

Table 20: Belgium Exchange Rate, 2002

Table 21: Canada Biotechnology Market Value: $ billion, 2002-2006

Table 22: Canada Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 23: Canada Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 24: Canada Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 25: Canada Size of Population (million) , 2002-2006

Table 26: Canada GDP (1995=100), 2002-2006

Table 27: Canada Inflation, 2002-2006

Table 28: Canada Exchange Rate, 2002

Table 29: China Biotechnology Market Value: $ billion, 2002-2006

Table 30: China Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 31: China Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 32: China Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 33: China Size of Population (million) , 2002-2006

Table 34: China GDP (1995=100), 2002-2006

Table 35: China Inflation, 2002-2006

Table 36: China Exchange Rate, 2002

Table 37: France Biotechnology Market Value: $ billion, 2002-2006

Table 38: France Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 39: France Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 40: France Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 41: France Size of Population (million) , 2002-2006

Table 42: France GDP (1995=100), 2002-2006

Table 43: France Inflation, 2002-2006

Table 44: France Exchange Rate, 2002

Table 45: Germany Biotechnology Market Value: $ billion, 2002-2006

Table 46: Germany Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 47: Germany Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 48: Germany Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 49: Germany Size of Population (million) , 2002-2006

Table 50: Germany GDP (1995=100), 2002-2006

Table 51: Germany Inflation, 2002-2006

Table 52: Germany Exchange Rate, 2002

Table 53: Italy Biotechnology Market Value: $ billion, 2002-2006

Table 54: Italy Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 55: Italy Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 56: Italy Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 57: Italy Size of Population (million) , 2002-2006

Table 58: Italy GDP (1995=100), 2002-2006

Table 59: Italy Inflation, 2002-2006

Table 60: Italy Exchange Rate, 2002

Table 61: Japan Biotechnology Market Value: $ billion, 2002-2006

Table 62: Japan Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 63: Japan Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 64: Japan Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 65: Japan Size of Population (million) , 2002-2006

Table 66: Japan GDP (1995=100), 2002-2006

Table 67: Japan Exchange Rate, 2002

Table 68: Netherlands Biotechnology Market Value: $ million, 2002-2006

Table 69: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 70: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 71: Netherlands Biotechnology Market Value Forecast: $ million, 2006-2011

Table 72: Netherlands Size of Population (million) , 2002-2006

Table 73: Netherlands GDP (1995=100), 2002-2006

Table 74: Netherlands Exchange Rate, 2002

Table 75: Spain Biotechnology Market Value: $ million, 2002-2006

Table 76: Spain Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 77: Spain Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 78: Spain Biotechnology Market Value Forecast: $ million, 2006-2011

Table 79: Spain Size of Population (million) , 2002-2006

Table 80: Spain GDP (1995=100), 2002-2006

Table 81: Spain Inflation, 2002-2006

Table 82: Spain Exchange Rate, 2002

Table 83: United Kingdom Biotechnology Market Value: $ billion, 2002-2006

Table 84: United Kingdom Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 85: United Kingdom Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 86: United Kingdom Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 87: United Kingdom Size of Population (million) , 2002-2006

Table 88: United Kingdom GDP (1995=100), 2002-2006

Table 89: United Kingdom Inflation, 2002-2006

Table 90: United Kingdom Exchange Rate, 2002

Table 91: United States Biotechnology Market Value: $ billion, 2002-2006

Table 92: United States Biotechnology Market Segmentation I: % Share, by Value, 2006

Table 93: United States Biotechnology Market Segmentation II: % Share, by Value, 2006

Table 94: United States Biotechnology Market Value Forecast: $ billion, 2006-2011

Table 95: United States Size of Population (million) , 2002-2006

Table 96: United States GDP (1995=100), 2002-2006

Table 97: United States Inflation, 2002-2006

Table 98: Key Facts: Acambis PLC

Table 99: Key Financials: Acambis PLC

Table 100: Key Facts: Amgen Inc.

Table 101: Key Financials: Amgen Inc

Table 102: Key Facts: Biogen Idec, Inc.

Table 103: Key Financials: Biogen Idec, Inc.

List of Figures
Figure 1: Global Biotechnology Market Value: $ billion, 2002-2006

Figure 2: Global Biotechnology Market Segmentation I: % Share, by Value, 2006

Figure 3: Global Biotechnology Market Segmentation II: % Share, by Value, 2006

Figure 4: Drivers of Buyer Power in the Global Biotechnology Market, 2006

Figure 5: Drivers of Supplier Power in the Global Biotechnology Market, 2006

Figure 6: Factors Influencing the Likelihood of New Entrants in the Global Biotechnology Market, 2006

Figure 7: Factors Influencing the Threat of Substitutes in the Global Biotechnology Market, 2006

Figure 8: Drivers of Degree of Rivalry in the Global Biotechnology Market, 2006

Figure 9: Global Biotechnology Market Value Forecast: $ billion, 2006-2011

Figure 10: Asia-Pacific Biotechnology Market Value: $ billion, 2002-2006

Figure 11: Asia-Pacific Biotechnology Market Segmentation I: % Share, by Value, 2006

Figure 12: Asia-Pacific Biotechnology Market Segmentation II: % Share, by Value, 2006

Figure 13: Drivers of Buyer Power in the Asia-Pacific Biotechnology Market, 2006

Figure 14: Drivers of Supplier Power in the Asia-Pacific Biotechnology Market, 2006

Figure 15: Factors Influencing the Likelihood of New Entrants in the Asia-Pacific Biotechnology Market, 2006

Figure 16: Factors Influencing the Threat of Substitutes in the Asia-Pacific Biotechnology Market, 2006

Figure 17: Drivers of Degree of Rivalry in the Asia-Pacific Biotechnology Market, 2006

Figure 18: Asia-Pacific Biotechnology Market Value Forecast: $ billion, 2006-2011

Figure 19: Europe Biotechnology Market Value: $ billion, 2002-2006

Figure 20: Europe Biotechnology Market Segmentation I: % Share, by Value, 2006

Figure 21: Europe Biotechnology Market Segmentation II: % Share, by Value, 2006

Figure 22: Drivers of Buyer Power in the Biotechnology Market in Europe, 2006

Figure 23: Drivers of Supplier Power in the Biotechnology Market in Europe, 2006

Figure 24: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Europe, 2006

Figure 25: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Europe, 2006